Brief: Olix Pharmaceuticals Receives Milestone Payment From L'oreal
02/12/2025 01:37
OliX Pharmaceuticals Inc 226950.KQ: RECEIVES MILESTONE PAYMENT FROM L'OREAL Source text: [ID:] Further company coverage: 226950.KQ
Recent news on OliX Pharmaceuticals
See all newsBrief: Olix Pharmaceuticals - Olx501a Shows 29.2% Visceral Fat Reduction Versus 10.0% With Comparator In Obese Non-Human Primates
Brief: Olix Pharmaceuticals Receives Milestone Payment From L'oreal
Brief: OliX And Lilly Enter Global Licensing Agreement For Mash And Other Cardiometabolic Indications
Brief: Olix Pharmaceuticals Commences Patient Dosing In Phase 1 Clinical Trial Of Olx75016
Brief: Olix Pharmaceuticals Receives Hrec Approval To Initiate Phase 1 Clinical Trial Of Nash And Obesity Drug